HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Submacular hemorrhage secondary to congenital toxoplasmosis.

Abstract
We report the case of a patient with congenital toxoplasmosis and submacular hemorrhage caused by a neovascular membrane who underwent an intravitreal injection of C3F8 and bevacizumab, and had a good visual recovery.
AuthorsAna Luiza Fontes de Azevedo Costa, Thiago Gonçalves Dos Santos Martins, Francisco Javier Solano Moncada, Mário Martins dos Santos Motta
JournalEinstein (Sao Paulo, Brazil) (Einstein (Sao Paulo)) 2014 Jan-Mar Vol. 12 Issue 1 Pg. 106-8 ISSN: 2317-6385 [Electronic] Brazil
PMID24728255 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Contrast Media
  • Fluorocarbons
  • Bevacizumab
  • perflutren
Topics
  • Adolescent
  • Angiogenesis Inhibitors (administration & dosage)
  • Antibodies, Monoclonal, Humanized (administration & dosage)
  • Bevacizumab
  • Contrast Media
  • Female
  • Fluorocarbons
  • Humans
  • Intravitreal Injections (methods)
  • Retinal Hemorrhage (drug therapy, etiology)
  • Time Factors
  • Toxoplasmosis, Congenital (complications, drug therapy)
  • Treatment Outcome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: